09:51 AM EST - HLS Therapeutics Inc. : Will release its Q1 2025 financial results on Thursday, May 8. The Company will hold a conference call that same day at 8:30 a.m. ET to discuss its results. The call will be hosted by Craig Millian, Chief Executive Officer; John Hanna, Chief Financial Officer; and Brian Walsh, Chief Commercial Officer. HLS Therapeutics Inc.
shares T.HLS are trading unchanged at $4.21.
